Suro Capital [SSSS] vs Brookfield [BN] Detailed Stock Comparison
Suro Capital
NASDAQ
Loading...
Brookfield
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Suro Capital wins in 10 metrics, Brookfield wins in 6 metrics, with 0 ties. Suro Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Suro Capital | Brookfield | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 4.42 | 232.59 | Suro Capital |
| Price-to-Book Ratio | 0.95 | 2.46 | Suro Capital |
| Debt-to-Equity Ratio | 33.47 | 156.81 | Suro Capital |
| PEG Ratio | -0.01 | 11.49 | Suro Capital |
| EV/EBITDA | N/A | 14.75 | N/A |
| Profit Margin (TTM) | 2,015.30% | 0.73% | Suro Capital |
| Operating Margin (TTM) | -1,593.16% | 27.05% | Brookfield |
| EBITDA Margin (TTM) | N/A | 27.05% | N/A |
| Return on Equity | 29.40% | 0.95% | Suro Capital |
| Return on Assets (TTM) | -2.27% | 2.69% | Brookfield |
| Free Cash Flow (TTM) | $2.37M | $-3.60B | Suro Capital |
| Dividend Yield | 2.98% | N/A | N/A |
| 1-Year Return | 124.23% | 44.29% | Suro Capital |
| Price-to-Sales Ratio (TTM) | 74.64 | 1.24 | Brookfield |
| Enterprise Value | $231.41M | $455.84B | Brookfield |
| EV/Revenue Ratio | 83.11 | 5.45 | Brookfield |
| Gross Profit Margin (TTM) | N/A | 38.73% | N/A |
| Revenue per Share (TTM) | $0 | $55 | Brookfield |
| Earnings per Share (Diluted) | $1.97 | $0.29 | Suro Capital |
| Beta (Stock Volatility) | 1.74 | 2.19 | Suro Capital |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Suro Capital vs Brookfield Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Suro Capital | 0.23% | -0.34% | 4.32% | 15.54% | 46.22% | 48.72% |
| Brookfield | 1.87% | 1.20% | -0.09% | 14.96% | 24.23% | 15.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Suro Capital | 124.23% | 43.56% | -27.20% | 2.59% | -40.21% | -40.21% |
| Brookfield | 44.29% | 63.70% | 149.38% | 306.85% | 705.81% | 1,084.34% |
Performance & Financial Health Analysis: Suro Capital vs Brookfield
| Metric | SSSS | BN |
|---|---|---|
| Market Information | ||
| Market Cap | $206.39M | $103.45B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 340,060 | 2,772,840 |
| 90 Day Avg. Volume | 226,710 | 2,169,097 |
| Last Close | $8.70 | $66.56 |
| 52 Week Range | $3.75 - $9.12 | $43.61 - $68.75 |
| % from 52W High | -4.61% | -3.19% |
| All-Time High | $20.89 (Feb 06, 2012) | $68.75 (Jul 18, 2025) |
| % from All-Time High | -58.35% | -3.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.84% | -0.22% |
| Quarterly Earnings Growth | -10.04% | -0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 20.15% | 0.01% |
| Operating Margin (TTM) | -15.93% | 0.27% |
| Return on Equity (TTM) | 0.29% | 0.01% |
| Debt to Equity (MRQ) | 33.47 | 156.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.19 | $27.44 |
| Cash per Share (MRQ) | $2.09 | $8.32 |
| Operating Cash Flow (TTM) | $-3,321,491 | $8.95B |
| Levered Free Cash Flow (TTM) | $-7,395,670 | $-2,725,499,904 |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.98% | N/A |
| Last 12-Month Dividend | $0.25 | N/A |
Valuation & Enterprise Metrics Analysis: Suro Capital vs Brookfield
| Metric | SSSS | BN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 4.42 | 232.59 |
| Forward P/E | -14.26 | 11.49 |
| PEG Ratio | -0.01 | 11.49 |
| Price to Sales (TTM) | 74.64 | 1.24 |
| Price to Book (MRQ) | 0.95 | 2.46 |
| Market Capitalization | ||
| Market Capitalization | $206.39M | $103.45B |
| Enterprise Value | $231.41M | $455.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 83.11 | 5.45 |
| Enterprise to EBITDA | N/A | 14.75 |
| Risk & Other Metrics | ||
| Beta | 1.74 | 2.19 |
| Book Value per Share (MRQ) | $9.19 | $27.44 |
Financial Statements Comparison: Suro Capital vs Brookfield
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SSSS | BN |
|---|---|---|
| Revenue/Sales | $2.09M | $17.94B |
| Cost of Goods Sold | N/A | $11.00B |
| Gross Profit | N/A | $6.95B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $4.48B |
| EBITDA | N/A | $8.23B |
| Pre-Tax Income | $-806,715 | $598.00M |
| Income Tax | N/A | $383.00M |
| Net Income (Profit) | $-806,715 | $215.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SSSS | BN |
|---|---|---|
| Cash & Equivalents | $16.18M | $12.44B |
| Total Current Assets | N/A | $65.21B |
| Total Current Liabilities | N/A | $58.80B |
| Long-Term Debt | $73.25M | $245.86B |
| Total Shareholders Equity | $156.80M | $158.93B |
| Retained Earnings | $-7.96M | N/A |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SSSS | BN |
|---|---|---|
| Operating Cash Flow | $-340,868 | $3.48B |
| Capital Expenditures | N/A | $-1.83B |
| Free Cash Flow | $-3.72M | $4.00M |
| Debt Repayment | $-4.95M | $-20.53B |
| Common Stock Repurchase | N/A | $-136.00M |
Short Interest & Institutional Ownership Analysis
| Metric | SSSS | BN |
|---|---|---|
| Shares Short | 137,566 | 15.19M |
| Short Ratio | 0.76 | 8.18 |
| Short % of Float | 0.01% | N/A |
| Average Daily Volume (10 Day) | 340,060 | 2,772,840 |
| Average Daily Volume (90 Day) | 226,710 | 2,169,097 |
| Shares Outstanding | 23.60M | 1.51B |
| Float Shares | 21.91M | 1.17B |
| % Held by Insiders | 0.08% | 0.18% |
| % Held by Institutions | 0.21% | 0.58% |
Dividend Analysis & Yield Comparison: Suro Capital vs Brookfield
| Metric | SSSS | BN |
|---|---|---|
| Last 12-Month Dividend | $0.25 | N/A |
| Last 12-Month Dividend Yield | 2.98% | N/A |
| 3-Year Avg Annual Dividend | $0.08 | N/A |
| 3-Year Avg Dividend Yield | 2.98% | N/A |
| 3-Year Total Dividends | $0.25 | N/A |
| Ex-Dividend Date | Jul 21, 2025 | N/A |